ELITEK Side Effects

6964012-6 | Hypoperfusion, Hypotension, Metabolic Acidosis
on Sep 02, 2010 Male patient from UNITED STATES , 61 years of age, weighting 209.0 lb, was diagnosed with hyperuricaemia and was treated with Elitek (View Usage). Patient experienced the following unwanted or unexpected effects: hypoperfusion, hypotension, metabolic acidosis. Elitek dosage: 10.5 Mg Once Iv.

6960155-1 | Pain, Pruritus, Rash Vesicular, Skin Exfoliation, Stevens-johnson Syndrome
Patient was taking Elitek (View Usage). Patient had the following side effects: pain (What is pain?), pruritus, rash vesicular, skin exfoliation, stevens-johnson syndrome on Aug 23, 2010 from UNITED STATES Additional patient health information: Male patient , 42 years of age, weighting 158.7 lb, was diagnosed with infection (What is infection?) and. Elitek dosage: . During the same period patient was treated with ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), BACTRIM DS (View Bactrim Ds Review and Bactrim Ds Label ), HYDROXYUREA (View Hydroxyurea Review and Hydroxyurea Label ), CIPROFLOXACIN (View Ciprofloxacin Review and Ciprofloxacin Label ). Patient was hospitalized.

6765762-7 | Discomfort, Dyspnoea, Electrocardiogram Qrs Complex Prolonged, Electrocardiogram T Wave Peaked, Haemodynamic Instability, Hypersensitivity, Oxygen Saturation Decreased, Tachycardia
Adverse event was reported on Jun 08, 2010 by a Male patient taking Elitek (View Usage) (Dosage: ) was diagnosed with prophylaxis, burkitt's lymphoma and. Location: UNITED STATES , weighting 220.5 lb, After Elitek was administered, patient had the following side effects: discomfort, dyspnoea, electrocardiogram qrs complex prolonged, electrocardiogram t wave peaked, haemodynamic instability, hypersensitivity, oxygen saturation decreased, tachycardia. During the same period patient was treated with RITUXAN (View Rituxan Review and Rituxan Label ), DIPHENHYDRAMINE HYDROCHLORIDE (View Diphenhydramine Hydrochloride Review and Diphenhydramine Hydrochloride Label ), ALOXI (View Aloxi Review and Aloxi Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), PEPCID (View Pepcid Review and Pepcid Label ), TYLENOL (CAPLET) (View Tylenol (caplet) Review and Tylenol (caplet) Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ).

6635273-8 | Acidosis, Cardiac Arrest, Hyperkalaemia, Renal Failure Acute, Ventricular Tachycardia
on Nov 18, 2009 Female patient from UNITED STATES , 57 years of age, was treated with Elitek (View Usage). Patient experienced the following unwanted or unexpected effects: acidosis, cardiac arrest (What is cardiac arrest?), hyperkalaemia, renal failure acute, ventricular tachycardia. Elitek dosage: . During the same period patient was treated with ANTINEOPLASTIC AGENTS (View Antineoplastic Agents Review and Antineoplastic Agents Label ).


6479940-8 | Acidosis, Cardiac Arrest, Hyperkalaemia, Renal Failure Acute, Ventricular Tachycardia
on Nov 18, 2009 Female patient from UNITED STATES , 57 years of age, was treated with Elitek (View Usage). Patient had the following side effects: acidosis, cardiac arrest (What is cardiac arrest?), hyperkalaemia, renal failure acute, ventricular tachycardia. Elitek dosage: . During the same period patient was treated with ANTINEOPLASTIC AGENTS (View Antineoplastic Agents Review and Antineoplastic Agents Label ).

5782193-7 | Cardio-respiratory Arrest, Haemolysis, Methaemoglobinaemia, Off Label Use, Oxygen Saturation Decreased
Patient was taking Elitek (View Usage). After Elitek was administered, patient had the following side effects: cardio-respiratory arrest, haemolysis, methaemoglobinaemia, off label use, oxygen saturation decreased on Jun 13, 2008 from UNITED STATES Additional patient health information: Male patient , 40 years of age, . Elitek dosage: .

5607609-8 | Methaemoglobinaemia, Respiratory Distress
Adverse event was reported on Jan 28, 2008 by a Male patient taking Elitek (View Usage) (Dosage: 9 Mg X1 Iv) was diagnosed with non-hodgkin's lymphoma, prophylaxis, tumour lysis syndrome and. Location: UNITED STATES , 56 years of age, weighting 154.0 lb, Patient experienced the following unwanted or unexpected effects: methaemoglobinaemia, respiratory distress.

5288759-5 | Bradycardia, Cardiopulmonary Failure, Electrolyte Imbalance, Fluid Overload, Hyperkalaemia, Metabolic Abnormality Management, Oliguria
on Mar 30, 2007 Male patient from UNITED STATES , weighting 6.50 lb, was diagnosed with hyperuricaemia and was treated with Elitek (View Usage). Patient had the following side effects: bradycardia, cardiopulmonary failure, electrolyte imbalance, fluid overload, hyperkalaemia, metabolic abnormality management, oliguria. Elitek dosage: 0.1 Mg/kg Repeated 12 Hours Later. During the same period patient was treated with DAUNORUBICIN HCL (2 Mg/kg) (View Daunorubicin Hcl Review and Daunorubicin Hcl Label ). Patient was hospitalized.

5253398-9 | Hyperbilirubinaemia, Septic Shock
on Feb 26, 2007 Male patient from UNITED STATES , weighting 218.5 lb, was diagnosed with tumour lysis syndrome and was treated with Elitek (View Usage). After Elitek was administered, patient had the following side effects: hyperbilirubinaemia, septic shock. Elitek dosage: . During the same period patient was treated with IDARUBICIN HCL (View Idarubicin Hcl Review and Idarubicin Hcl Label ), CYTARABINE (View Cytarabine Review and Cytarabine Label ), NEXIUM (Unk) (View Nexium Review and Nexium Label ), SYNTHROID (Unk) (View Synthroid Review and Synthroid Label ), ZANAFLEX (Unk) (View Zanaflex Review and Zanaflex Label ), ELAVIL (Unk) (View Elavil Review and Elavil Label ), NEURONTIN (Unk) (View Neurontin Review and Neurontin Label ).

5247901-2 | Hyperbilirubinaemia, Renal Failure Acute, Septic Shock
Patient was taking Elitek (View Usage). Patient experienced the following unwanted or unexpected effects: hyperbilirubinaemia, renal failure acute, septic shock on Feb 15, 2007 from UNITED STATES Additional patient health information: Male patient , weighting 218.5 lb, was diagnosed with tumour lysis syndrome and. Elitek dosage: . During the same period patient was treated with IDARUBICIN HCL (Unk) (View Idarubicin Hcl Review and Idarubicin Hcl Label ), CYTARABINE (Unk) (View Cytarabine Review and Cytarabine Label ), NEXIUM (Unk) (View Nexium Review and Nexium Label ), SYNTHROID (Unk) (View Synthroid Review and Synthroid Label ), ZANAFLEX (Unk) (View Zanaflex Review and Zanaflex Label ), ELAVIL (Unk) (View Elavil Review and Elavil Label ), NEURONTIN (Unk) (View Neurontin Review and Neurontin Label ).

5241789-1 | Hyperbilirubinaemia, Renal Failure Acute, Septic Shock
Adverse event was reported on Feb 15, 2007 by a Male patient taking Elitek (View Usage) (Dosage: ) was diagnosed with tumour lysis syndrome and. Location: UNITED STATES , weighting 218.5 lb, Patient had the following side effects: hyperbilirubinaemia, renal failure acute, septic shock. During the same period patient was treated with IDARUBICIN HCL (Unk) (View Idarubicin Hcl Review and Idarubicin Hcl Label ), CYTARABINE (Unk) (View Cytarabine Review and Cytarabine Label ), NEXIUM (Unk) (View Nexium Review and Nexium Label ), SYNTHROID (Unk) (View Synthroid Review and Synthroid Label ), ZANAFLEX (Unk) (View Zanaflex Review and Zanaflex Label ), ELAVIL (Unk) (View Elavil Review and Elavil Label ), NEURONTIN (Unk) (View Neurontin Review and Neurontin Label ).

4653015-2 | Methaemoglobinaemia
on May 02, 2005 Male patient from UNITED STATES , child 6 years of age, weighting 52.91 lb, was diagnosed with tumour lysis syndrome and was treated with Elitek (View Usage). After Elitek was administered, patient had the following side effects: methaemoglobinaemia. Elitek dosage: 4.4 Mg X 1 Dose Iv. During the same period patient was treated with CYTOXAN (View Cytoxan Review and Cytoxan Label ), MESNA (View Mesna Review and Mesna Label ).